论文部分内容阅读
Antitumor activity and safety of pembrolizumab in patients (pts) with advanced squamous cell carcino
【作 者】
：
【机 构】
：
TheUniversityofChicago,Chicago,ILDana-FarberCancerInstitute,Boston,MAH.LeeMoffittCancerCenterandRese
【出 处】
：
2015年临床肿瘤学新进展学术研讨会
【发表日期】
：
2015年7期
其他文献
The survival benefit offered by the surgical management of low-grade ductal carcinoma in situ of the
会议
Low-dose oral cyclophosphamide-methotrexate maintenance (CMM) for receptor-negative early breast can
会议
Randomized phase Ⅱ study of everolimus (E) versus everolimus plus bevacizumab (E+B) in patients (Pts
会议
SIRFLOX Randomized phase Ⅲ trial comparing first-line mFOLFOX6 ± bevacizumab (bev) versus mFOLFOX6 +
会议
PET-NECK A multi-centre, randomized, phase Ⅲ, controlled trial (RCT) comparing PETCT guided active s
会议